Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
U.S. Specialized Therapeutics revenues down 2% in the quarter
May 7, 2019
By: Kristin Brooks
Managing Editor, Contract Pharma
Allergan 1Q Revenues: $3.6 billion (-2%) 1Q Loss: $2.4 billion (loss of $284 million 1Q18) Comments: U.S. Specialized Therapeutics revenues were $1.5 billion in the quarter, down 2%. BOTOX Therapeutic, BOTOX Cosmetic and JUVÉDERM Collection growth was partially offset by a decline in CoolSculpting sales, lower RESTASIS revenues due to lower net pricing, as well as the divestiture of the Company’s Medical Dermatology business on September 2018. BOTOX Therapeutic sales in the quarter were $397.6 million, up 6%. RESTASIS sales were $231.7 million, down 9%. ALPHAGAN/COMBIGAN sales were $83.0 million, down 1%. OZURDEX revenues were $30.3 million, up 19%. U.S. General Medicine revenues were $1.3 billion, up 2%, primarily due to growth in VRAYLAR and Lo LOESTRIN, partially offset by lower revenues from products that lost exclusivity. VRAYLAR revenues were $143.7 million, up 70%. VIIBRYD/FETZIMA sales were $85.0 million, up 19%. LINZESS sales were $161.3 million, up 1%. Lo LOESTRIN sales were $125.8 million, up 10%. BYSTOLIC/BYVALSON sales were $128.3 million, down 3%.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !